Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Defence Therapeutics Inc (DTCFF)
:DTCFF
DTCFF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.27 - $1.87
Previous CloseN/A
Volume8.00K
Average Volume (3M)14.00K
Market Cap
$47.45M
Enterprise Value$26.76M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding47,086,674
10 Day Avg. Volume2,385
30 Day Avg. Volume13,999
Standard Deviation0.44
R-Squared0.08
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)170.40
P/FCF Ratio170.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Defence Therapeutics News
PremiumCompany Announcements
Defence Therapeutics Secures $3.9 Million to Boost Biotech Initiatives
PremiumCompany Announcements
Defence Therapeutics Strengthens Patent Portfolio, Secures Market Exclusivity
PremiumCompany Announcements
Defence Therapeutics Announces $4.2M Private PlacementPremiumCompany Announcements
Defence Therapeutics Strengthens Leadership with Key Appointments
PremiumCompany Announcements
IC Capitalight Reports New Exploration ResultsPremiumCompany Announcements
Defence Therapeutics to License Accum TechnologyPremiumCompany Announcements
Defence Therapeutics Welcomes New CSO to Drive Growth---
Options Prices
Currently, No data available
---
Ownership Overview
DTCFF FAQ
What was Defence Therapeutics Inc’s price range in the past 12 months?
Defence Therapeutics Inc lowest stock price was $0.27 and its highest was $1.87 in the past 12 months.
What is Defence Therapeutics Inc’s market cap?
Defence Therapeutics Inc’s market cap is $47.45M.
When is Defence Therapeutics Inc’s upcoming earnings report date?
Defence Therapeutics Inc’s upcoming earnings report date is Mar 04, 2025 which is in 12 days.
How were Defence Therapeutics Inc’s earnings last quarter?
Defence Therapeutics Inc released its earnings results on Nov 12, 2024. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.
Is Defence Therapeutics Inc overvalued?
According to Wall Street analysts Defence Therapeutics Inc’s price is currently Overvalued.
Does Defence Therapeutics Inc pay dividends?
Defence Therapeutics Inc does not currently pay dividends.
What is Defence Therapeutics Inc’s EPS estimate?
Defence Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Defence Therapeutics Inc have?
Defence Therapeutics Inc has 47,086,674 shares outstanding.
What happened to Defence Therapeutics Inc’s price movement after its last earnings report?
Defence Therapeutics Inc reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Defence Therapeutics Inc?
Currently, no hedge funds are holding shares in DTCFF
---
Company Description
Defence Therapeutics Inc
Defence Therapeutics Inc is engaged in the development of anti-body drug conjugates that improve the efficacy and safety of nano and protein-based pharmaceuticals used in the treatment of cancer.
---
Technical Analysis
---